Clinical Trial Update: Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol [Phase 4]

View source ↗

Summary

This document describes the protocol for the Phase 4 GABS-DART trial evaluating gabapentin in breast surgery decision-making, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Breast Cancer | Phase 4 | Status: RECRUITING